Insulin pumps

Archives of Disease in Childhood

Volumn 88, Issue 11, 2003, Pages 949-953

  Torrance, T ^a   Franklin, V ^a   Greene, S ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; HYPOSTOP; INSULIN; INSULIN ASPART; INSULIN LISPRO; ISOPHANE INSULIN; NEUTRAL INSULIN; UNCLASSIFIED DRUG;

BEHAVIOR MODIFICATION; CARBOHYDRATE INTAKE; CLINICAL TRIAL; CONTINUOUS INFUSION; DEVICE INFECTION; DIABETES CONTROL; DIABETIC KETOACIDOSIS; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; INSULIN SENSITIVITY; METABOLIC REGULATION; NATIONAL HEALTH SERVICE; NOCTURNAL HYPOGLYCEMIA; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; RETINOPATHY;

ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; HUMANS; HYPOGLYCEMIA; INFUSION PUMPS, IMPLANTABLE; INSULIN; INSULIN INFUSION SYSTEMS;

EID: 0345377635     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.88.11.949     Document Type: Editorial

References (33)

1. Greene SA, Sith MA, Baum JD. Clinical application of insulin pumps in young adults and children with insulin dependent diabetes mellitus. Arch Dis Child 1983;58:578-81.
2. Knight G, Boulton AJ, Ward JD. Experience of continuous subcutaneous insulin infusion in the outpatient management of diabetic teenagers. Diabet Med 1986;3:82-4.
3. INPUT (insulin pump therapy). Average costs of insulin pump therapy. 2001. http:// www.geocities.com/Vienna.Strasse/5726/input. Accessed 2/8/02.
4. Tamborlane WV, Bonfig W, Boland E. Recent advances in treatment of youth with type 1 diabetes: better care through technology. Diabet Med 2001;18:864-70.
5. Boland EA, Grey M, Oesterle A, et al. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999;22:1779-84.
6. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
7. White NH, Cleary PA, Dahms W, et al. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr 2001;139:804-12.
8. The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995;4:968-83.
9. Mortensen HB, Marinelli K, Norgaard K et al, and the Danish Study Group of Diabetes in Childhood. A nationwide cross-sectional study of urinary albumin excretion rate, arterial blood pressure and blood glucose control in Danish children with type 1 diabetes mellitus. Diabet Med 1990;7:887-97.
10. Lenhard MJ, Reeves GD. Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med 2001;161:2293-300.
11. Pickup JC. Is insulin pump treatment justifiable? In: Gill G, Pickup J, Williams G, eds. Unstable and difficult diabetes. Oxford: Blackwell Science, 2003.
12. Greene AC, Tripaldi M, McKeirnan P, et al. Promoting empowerment in young people with type 1 diabetes. Diabet Med 1999;16(suppl 1):20.
13. Scottish Intercollegiate Guideline Network (SIGN). Children and young people. Publication 55. Scottish Executive. 2001.
14. Scottish Study Group for the Care of the Young Diabetic. Factors influencing glycaemic control in young people with type 1 diabetes in Scotland: a population based study (Diabaud2). Diabetes Care 2001;24:239-44.
15. Pickup J, Keen H. Continuous subcutaneous insulin infusion in type 1 diabetes. BMJ 2001;322:1262-3.
16. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 Diabetes. Diabetes Care 2002;25:593-8.
17. Newton RW. Conference for young diabetics. Diabet Med 1987;4:335-6.
18. Bergada I, Suissa S, Dufresna J, et al. Severe hypoglycaemia in IDMM children. Diabetes Care 1989;12:239-44.
19. Rudolf MC, Ahern JA, Genel M, et al. Optimal insulin delivery in adolescents with diabetes: impact of intensive treatment on psychosocial adjustment. Diabetes Care 1982;5(suppl 1):53-7.
20. Brink SJ. How to apply the experience from the diabetes control and complications trial to children and adolescents? Ann Med 1997;5:425-38.
21. Bogestig M, Arnqvist HJ, Hermansson G, et al. Declining incidence of neuropathy in insulin dependent diabetes mellitus. N Engl J Med 1994;330:15-18.
22. Dorchy H. What glycaemic control can be obtained in young diabetics without residual endogenous insulin secretion? What is the frequency of hypoglycaemia and subclinical complications? Arch Paediatr 1994;1:970-81.
23. Greene SA. Diabetes in childhood and adolescence. In: Pickup J, Williams G, eds. Textbook of diabetes, 2nd edn. Oxford: Blackwell Science, 1997.
24. Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 2002;324:705.
25. Hanas R. Selection for and initiation of continuous subcutaneous insulin infusion. Proceedings from a workshop. Horm Res 2002;57(suppl 1):101-4.
26. Matyka KA, Crawford C, Wiggs L, et al. Alterations in sleep physiology in young children with insulin-dependent diabetes mellitus: relationship to nocturnal hypoglycemia. J Pediatr 2000;137:233-8.
27. Kaufman FR, Halvorson M, Kim C, et al. Use of insulin pump therapy at nighttime only for children 7-10 years of age with type 1 diabetes. Diabetes Care 2000 May;23:579-82.
28. Wredling RA, Adamson UK, Lins PE. Alteration of the risk factor paradigm for discontinuance of insulin pump therapy. Diabetes Care 1994;17:942-3.
29. Bode B, Weinstein R, Bell D, et al. Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes. Diabetes Care 2002;25:439-44.
30. Bode BW, Tamborlane WV, Davidson PC. Insulin pump therapy in the 21st century. Strategies for successful use in adults, adolescents, and children with diabetes. Postgrad Med 2002;111:69-77.
31. Schmauss S, Konig A, Landgraf R. Human insulin analogue [LYS(B28), PRO(B29)]: the ideal pump insulin? Diabet Med 1998;15:247-9.
32. Conrad SC, McGrath MT, Gitelman SE. Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitus. J Pediatr 2002;140:235-40.
33. Stein C. Psychological reactions to insulin infusion pumps. Med Clin North Am 1982;66:1285-92.